Therapeutic and antiproteinuric effects of salvianolic acid A in combined with low-dose prednisone in minimal change disease rats: Involvement of PPARγ/Angptl4 and Nrf2/HO-1 pathways-Reference-Cited by-同舟云学术

Therapeutic and antiproteinuric effects of salvianolic acid A in combined with low-dose prednisone in minimal change disease rats: Involvement of PPARγ/Angptl4 and Nrf2/HO-1 pathways

Published:2019-09 Issue: Volume:858 Page:172342
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Wang Xuekai,Qi Dong,Fu Fenghua,Li Xin,Liu Yue,Ji Kai,Gao Zhenfang,Kong Linlin,Yu Chen,Xie Hua,Yue Guang,Zhu Hui,Liu Ke,Fan Huaying

Funder

Shandong Provincial Natural Science Foundation, China

Project of Key Research and Development Plan of Yantai

Project of Graduate Innovation Foundation of Yantai University, GIFYTU

Publisher

Elsevier BV

Subject

Pharmacology

Reference53 articles.

1. Novel multidrug therapy for children with cyclosporine-resistant or -intolerant nephrotic syndrome;Aizawa-Yashiro;Pediatr. Nephrol.,2011

2. Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events;Bertani;Lab. Investig.,1982

3. Pathogenesis of proteinuria in idiopathic minimal change disease: molecular mechanisms;Cara-Fuentes;Pediatr. Nephrol.,2016

4. Angiopoietin-like-4 and minimal change disease;Cara-Fuentes;PLoS One,2017

5. Podocyte injury and repair mechanisms;Cellesi;Curr. Opin. Nephrol. Hypertens.,2015

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxymatrine and Gut Microbiota Modulation: A Potential Therapeutic Strategy for Bone Cancer Pain Management;The Journal of Pain;2024-10

2. The ANGPTL4-HIF-1α loop: a critical regulator of renal interstitial fibrosis;Journal of Translational Medicine;2024-07-11

3. Insight into the role of angiopoietin‑like protein 4 in podocypopathies (Review);World Academy of Sciences Journal;2024-04-19

4. Effectiveness of Chinese herbal medicine compared with angiotensin II receptor blockers in patients with diabetic kidney disease: A hospital-based matched cohort study;Journal of Traditional and Complementary Medicine;2023-11

5. Flavonoids-mediated TLR4 Inhibition as a Promising Therapy for Renal Diseases;Combinatorial Chemistry & High Throughput Screening;2023-10